Sabby Management »

Briacell Therapeutics Corp shares owned by Sabby Management

Quarter-by-quarter ownership of Briacell Therapeutics Corp (BCTX) shares owned by Sabby Management from 13F filings

Historical chart of Sabby Management investment in Briacell Therapeutics Corp

Tip: Access up to 7 years of quarterly data

All positions including Briacell Therapeutics Corp held by Sabby Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Briacell Therapeutics Corp by Sabby Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $98k 34k 2.86

More positions owned by Sabby Management

Spdr S&p 500 Etf Tr Etf Put Option
Ishares Tr Etf Put Option
Spdr S&p 500 Etf Tr Etf Call Option
Ishares Tr Etf Call Option
Vivani Medical (VANI)
Eltek SHS (ELTK)
Core Scientific Note (Principal)
Redhill Biopharma Ads (RDHL)
Tonix Pharmaceuticals Hldg
Global Mofy Metaverse Ord (GMM)
China Natural Resources SHS (CHNR)
Checkpoint Therapeutics Put Option
Bit Digital SHS Put Option
Recon Technology Cl A
Biovie Cl A (BIVI)

View all positions for Sabby Management

Top funds holding Briacell Therapeutics Corp

Redmond Asset Management
Vontobel Holding
Hrt Financial
Citadel Advisors
Onyx Bridge Wealth Group
Group One Trading
Summit Trail Advisors
LPL Financial
Cambridge Investment Research Advisors
HighTower Advisors
Concord Wealth Partners
Susquehanna International
National Bank Of Canada /fi/
Royal Bank of Canada
TD Waterhouse Canada

View all funds holding Briacell Therapeutics Corp